MIAMI, FL / ACCESS Newswire / December 17, 2025 / KIFFIK Biomedical announced today the successful close of its Series A financing, completed ahead of schedule and significantly oversubscribed. The ...

In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and ...

As per SNS Insider Research, The Global Syndromic Multiplex Diagnostics Market Growth is Driven by Advancements in Molecular Diagnostics, Rising Burden of Infectious Diseases and Growing Demand for ...

Next-gen diagnostics: Advances in molecular platforms, informatics and AI enable smarter, more personalized care. Innovation ...

Alveo Technologies, a leader in molecular sensing and diagnostics with its proprietary molecular detection technology, today ...

Innovation in biotech is quickly becoming one of the most important drivers of U.S. competitiveness. As artificial ...

The Southern blot, which detects specific DNA sequences, was one of the first molecular diagnostic methods to be widely adopted. 2 This type of probe-based assay uses a single-stranded oligonucleotide ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, is a leader in diagnostic information services. The company operates numerous patient service centers and laboratories ...

Antibiotic resistance is one of the most pressing—and quietly advancing—challenges facing modern medicine. Among the most ...

Nearly 100 scientists, young researchers, doctoral candidates and students from 14 countries have gathered for the ...

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.34 since the market last closed. This is a 6.09% ...